Global leader in implants selects clinivation to advance multinational market access initiatives.
NATICK, MA – March 20, 2010 – Clinivation, Inc. is pleased to announce today that Biomet has selected clinivation to advance certain multinational market access initiatives.
Ever-proliferating and changing global regulations generate complex challenges of execution in global market clearance operations.
Clinivation’s experienced Technology-Enabled CRO Services team understands how to approach and overcome complex development, quality, regulatory, and market access hurdles.
Unlike traditional consulting, Technology-Enabled CRO Services can employ domain-specific information technology to achieve a high operational tempo and an operational fluidity that advances to milestones and deliverables with quality and efficiency.
Quotes & Commentary:
“We look forward working with the Biomet teams around the world and in the U.S., and advancing the multinational market access initiatives,” said clinivation Founder and CEO Joseph Kozikowski, M.D.
For more information on the clinivation’s Technology-Enabled CRO Services, please visit the clinivation CRO Services homepage
For more information on the clinivation Enterprise Solution for Global Market Clearance Management, please visit the clinivation Global homepage.
For more information on the clinivation Enterprise Solution for On-Demand Global Regulatory Intelligence, please visit the clinivation WorldView homepage.
Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet’s product portfolio encompasses reconstructive products, including orthopedic joint replacement devices, bone cements and accessories, autologous therapies and dental reconstructive implants; fixation products, including electrical bone growth stimulators, internal and external orthopedic fixation devices, craniomaxillofacial implants and bone substitute materials; spinal products, including spinal stimulation devices, spinal hardware and orthobiologics; and other products, such as arthroscopy products and softgoods and bracing products.